Market research
Why Eli Lilly is the New “Big Tech” of Healthcare
While competitor guidance falters, Eli Lilly is projecting a 2026 revenue target of over $80 billion. From the 'hockey stick' growth visible in our Revenue & Profitability charts to the massive capital investments in automated sites, the numbers tell a story of total market dominance. This article breaks down the shift from needles to pills and why institutional sentiment remains at a robust 89% despite massive price jumps.
